ENTA
Price
$7.54
Change
+$0.09 (+1.21%)
Updated
Sep 17 closing price
Capitalization
159.27M
60 days until earnings call
PMVP
Price
$1.25
Change
+$0.05 (+4.17%)
Updated
Sep 17 closing price
Capitalization
63.59M
49 days until earnings call
Interact to see
Advertisement

ENTA vs PMVP

Header iconENTA vs PMVP Comparison
Open Charts ENTA vs PMVPBanner chart's image
Enanta Pharmaceuticals
Price$7.54
Change+$0.09 (+1.21%)
Volume$219.55K
Capitalization159.27M
PMV Pharmaceuticals
Price$1.25
Change+$0.05 (+4.17%)
Volume$1.51M
Capitalization63.59M
ENTA vs PMVP Comparison Chart in %
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. PMVP commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Buy and PMVP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ENTA: $7.55 vs. PMVP: $1.25)
Brand notoriety: ENTA and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 124% vs. PMVP: 116%
Market capitalization -- ENTA: $159.27M vs. PMVP: $63.59M
ENTA [@Biotechnology] is valued at $159.27M. PMVP’s [@Biotechnology] market capitalization is $63.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ENTA and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • ENTA’s TA Score: 5 bullish, 5 bearish.
  • PMVP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ENTA and PMVP are a good buy in the short-term.

Price Growth

ENTA (@Biotechnology) experienced а -9.36% price change this week, while PMVP (@Biotechnology) price change was -1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

ENTA is expected to report earnings on Nov 17, 2025.

PMVP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($159M) has a higher market cap than PMVP($63.6M). ENTA YTD gains are higher at: 31.304 vs. PMVP (-17.219). ENTA has higher annual earnings (EBITDA): -82.41M vs. PMVP (-91.02M). ENTA has more cash in the bank: 204M vs. PMVP (142M). PMVP has less debt than ENTA: PMVP (1.02M) vs ENTA (58M). ENTA has higher revenues than PMVP: ENTA (64.8M) vs PMVP (0).
ENTAPMVPENTA / PMVP
Capitalization159M63.6M250%
EBITDA-82.41M-91.02M91%
Gain YTD31.304-17.219-182%
P/E RatioN/AN/A-
Revenue64.8M0-
Total Cash204M142M144%
Total Debt58M1.02M5,686%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAPMVP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
71%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GHYLF0.30N/A
N/A
Gold Hydrogen Limited
BSFAF0.04N/A
N/A
BSF Enterprise Plc
SIGGF1.98N/A
N/A
Sigma Healthcare Limited
GIVSY23.65N/A
N/A
Grupo De Inversiones Suramericana S.A.
RMLFF0.97-0.01
-0.55%
Rusoro Mining Ltd.

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with BEAM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+1.34%
BEAM - ENTA
38%
Loosely correlated
-1.86%
VRDN - ENTA
37%
Loosely correlated
-0.21%
ADCT - ENTA
35%
Loosely correlated
-1.81%
AKRO - ENTA
35%
Loosely correlated
-0.99%
ANAB - ENTA
34%
Loosely correlated
+2.11%
More